Cannabis consulting for Hawaii

The Hawaii landscape

Hawaii operates a medical cannabis dispensary program overseen by the Department of Health. The program posts interim dispensary rules effective November 17, 2025. Manufactured hemp has a separate framework, including a retailer and distributor registration requirement beginning in 2026; the two product channels should not be treated as interchangeable.

Official references: Hawaii DOH: medical cannabis dispensary program ↗Hawaii DOH: manufactured hemp program ↗

Separate medical production from hemp product planning

For a Hawaii business, begin by identifying the intended product and lawful channel. A medical production review can examine consistency, storage, packaging, and release decisions. A hemp project needs its own review of product eligibility, registration, supplier records, and distribution arrangements.

• Which regulatory framework applies to each proposed product?
• Are supply interruptions and storage conditions reflected in the operating plan?
• Who verifies that specifications and labels remain aligned with the intended channel?

What comes next

Plan for today’s medical market and model a separate adult-use scenario if policy changes. Identify what would need to change in capacity, equipment, staffing, product mix, inventory, and distribution. Prioritize improvements that are useful now; make expansion spending conditional on enacted rules and an available licensing route. A medical license does not automatically establish adult-use eligibility.

Before modeling adult-use expansion, strengthen the systems that support the existing medical operation. For any future scenario, separately assess site permissions, permitted products, transport arrangements, and licensing eligibility.

Planning scenarios are conditional. Confirm current state and local requirements, product eligibility, and any necessary approvals before acting. Operational consulting complements advice from qualified legal, tax, and licensed design professionals.